These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2314727)

  • 1. Food and Drug Administration halves dosage for AZT.
    N Y State J Med; 1990 Mar; 90(3):168. PubMed ID: 2314727
    [No Abstract]   [Full Text] [Related]  

  • 2. Dosage guidelines modified for Retrovir.
    Oncology (Williston Park); 1990 Mar; 4(3):14. PubMed ID: 2144442
    [No Abstract]   [Full Text] [Related]  

  • 3. Generic AZT cleared for use.
    AIDS Patient Care STDS; 2005 Nov; 19(11):780. PubMed ID: 16320374
    [No Abstract]   [Full Text] [Related]  

  • 4. AZT finally approved for pediatric use.
    Katzin L
    Am J Nurs; 1990 Jul; 90(7):18. PubMed ID: 2363452
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA approves the distribution of AZT for children.
    J Pract Nurs; 1989 Dec; 39(4):9. PubMed ID: 2600877
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA halves AZT dose.
    Am Pharm; 1990 May; NS30(5):18. PubMed ID: 2337016
    [No Abstract]   [Full Text] [Related]  

  • 7. Retrovir approved for use in children.
    Pediatr Nurs; 1990; 16(5):478. PubMed ID: 2216573
    [No Abstract]   [Full Text] [Related]  

  • 8. AZT given the green light for clinical treatment of AIDS.
    Ezzell C
    Nature; 1987 Apr 2-8; 326(6112):430. PubMed ID: 3470603
    [No Abstract]   [Full Text] [Related]  

  • 9. AZT indication extended to use in children.
    J Am Osteopath Assoc; 1990 Jan; 90(1):16, 19. PubMed ID: 2312366
    [No Abstract]   [Full Text] [Related]  

  • 10. AIDS: AZT for children in extended US trial.
    Lindley D
    Nature; 1989 Nov; 342(6245):10. PubMed ID: 2811993
    [No Abstract]   [Full Text] [Related]  

  • 11. Labeling revised for longterm dosage of AZT.
    J Am Osteopath Assoc; 1990 Jun; 90(6):487. PubMed ID: 2351577
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical trial that led to FDA approval of zidovudine is published.
    Clin Pharm; 1987 Oct; 6(10):752. PubMed ID: 3333341
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA Committee recommends clearance for HIVID combination therapy.
    AIDS Patient Care STDS; 1996 Jun; 10(3):186. PubMed ID: 11361630
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA clearance for ritonavir in children with AIDS.
    AIDS Patient Care STDS; 1997 Jun; 11(3):194. PubMed ID: 11361797
    [No Abstract]   [Full Text] [Related]  

  • 15. Zidovudine approved by FDA for treatment of AIDS.
    Clin Pharm; 1987 Jun; 6(6):431,435. PubMed ID: 3319360
    [No Abstract]   [Full Text] [Related]  

  • 16. Potent new AIDS drugs underscore promise of combination therapy.
    AIDS Alert; 1996 Jan; 11(1):1-4. PubMed ID: 11363225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epoetin alpha approved for anemic AIDS patients.
    J Am Osteopath Assoc; 1991 Jun; 91(6):538. PubMed ID: 1874651
    [No Abstract]   [Full Text] [Related]  

  • 18. AIDS drug brings providers challenge of distribution.
    Taravella S
    Mod Healthc; 1989 Sep; 19(39):38-9. PubMed ID: 10303961
    [No Abstract]   [Full Text] [Related]  

  • 19. AZT, ddI, and ddC combinations at FDA advisory hearing. Food and Drug Administration.
    James JS
    AIDS Treat News; 1996 Apr; (no 244):6. PubMed ID: 11363307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controversial findings of VA AZT trial.
    J Am Osteopath Assoc; 1991 Apr; 91(4):332. PubMed ID: 1874641
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.